Thermogenesis Holdings (THMO) could be a great long-term investment
What’s up with Thermogenesis Holdings?
Thermogenesis Holdings(THMO) opened at $8.12, which means the stock is down 11.84% from yesterday’s closing price of 8.11. Today, the company has a high of $8.19 and a low of $6.85. The stock holds a market cap of $41.25 million which is impressive since the P/E ratio is 26.92. The company has a 52-week high of $10.16 and a 52-week low of $1.63.
What is P/E ratio?
The price-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of a company’s share price to the company’s earnings per share. The ratio is used for valuing companies and to find out whether they are overvalued or undervalued. Thermogenesis Holdings has a strong.A higher P/E ratio shows that investors are willing to pay a higher share price today because of growth expectations in the future.
About Thermogenesis Holdings
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.